TY  - GEN
AU  - Mondelo-Macia, Patricia
AU  - Rodriguez-Lopez, Carmela
AU  - Valina, Laura
AU  - Aguin, Santiago
AU  - Leon-Mateos, Luis
AU  - Garcia-Gonzalez, Jorge
AU  - Abalo, Alicia
AU  - Rapado-Gonzalez, Oscar
AU  - Suarez-Cunqueiro, Mercedes
AU  - Diaz-Lagares, Angel
AU  - Curiel, Teresa
AU  - Calabuig-Farinas, Silvia
AU  - Azkárate, Aitor
AU  - Obrador-Hevia, Antonia
AU  - Abdulkader, Ihab
AU  - Muinelo-Romay, Laura
AU  - Diaz-Pena, Roberto
AU  - Lopez-Lopez, Rafael
PY  - 2020
DO  - 10.3390/cells9020522
UR  - https://hdl.handle.net/20.500.12105/22940
AB  - MET alterations may provide a potential biomarker to evaluate patients who will benefit from treatment with MET inhibitors. Therefore, the purpose of the present study is to investigate the utility of a liquid biopsy-based strategy to assess MET...
LA  - eng
PB  - Multidisciplinary Digital Publishing Institute (MDPI)
KW  - MET protein expression
KW  - MET amplification
KW  - Circulating free DNA (cfDNA)
KW  - Circulating tumor cells (CTCs)
KW  - Targeted therapy
KW  - MET copy number
KW  - Case-Control Studies
KW  - Humans
KW  - ErbB Receptors
KW  - Antineoplastic Agents
KW  - Liquid Biopsy
KW  - Protein Kinase Inhibitors
KW  - Neoplasms
KW  - Male
KW  - Prospective Studies
KW  - Gene Dosage
KW  - Proto-Oncogene Proteins c-met
KW  - Biomarkers, Tumor
KW  - Female
KW  - Neoplastic Cells, Circulating
KW  - Drug Resistance, Neoplasm
KW  - Cell-Free Nucleic Acids
KW  - Retrospective Studies
TI  - Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients
TY  - research article
ER  -